Loading institutional data...
Loading institutional data...
Held by 1,873 of 5,944 reporting institutions (100th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 31%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $1.3B covers the $1.1B due within a year 1.2× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~3.9% on $6.9B of debt.
Cash of $1.3B fully covers short-term debt of $1.1B.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Ranked against 235 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $896.8B | 41.1× | — | 1.3× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $417.5B | 51.7× | 31.9× | 1.5× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.4× | 4,050 |
| KO | $373.6B | 28.6× | 24.5× | 7.8× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $345.0B | 22.6× | 16.3× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $294.0B | 26.0× | 17.1× | 7.2× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $190.0B | 23.1× | 15.4× | 2.0× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| BUDFF | $151.5B | — | — | — | — | — | — | — | — | — | 5 |
| UNLYF | $138.7B | — | — | — | — | — | — | — | — | — | 23 |
| MO | $114.6B | 16.6× | 13.2× | 4.9× | -3.1% | 62.5% | 29.8% | -198% | 33.7% | 2.4× | 2,375 |
| MNST | $92.4B | — | 35.6× | 11.1× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| MDLZ | $81.0B | 33.1× | 19.0× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| CL | $74.7B | 35.5× | 20.4× | 3.7× | 1.4% | 60.1% | 10.5% | 3948% | 30.8% | 1.7× | 1,873 |
| TGT | $66.9B | 18.2× | 9.8× | 0.6× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| DGEAF | $54.3B | — | — | — | — | — | — | — | — | — | 4 |
| CCEP | $48.8B | — | — | — | — | — | — | — | — | — | 543 |
| ABEV | $47.8B | — | — | — | — | — | — | — | — | — | 383 |
| JBS | $45.1B | — | — | — | — | — | — | — | — | — | 241 |
| FMX | $42.4B | — | — | — | — | — | — | — | — | — | 290 |
| KDP | $41.8B | 20.1× | 14.1× | 2.5× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| SYY | $41.1B | 22.6× | 10.3× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| KVUE | $37.7B | 25.9× | 15.7× | 2.5× | -2.1% | 58.1% | 9.7% | 13.7% | 7.1% | 3.4× | 967 |
| ADM | $37.6B | 34.8× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| KMB | $37.3B | 18.5× | 11.8× | 2.3× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KR | $37.0B | 36.8× | 9.2× | 0.3× | 0.4% | — | 0.7% | 17.1% | 5.0% | 2.8× | 1,327 |
| HSY | $36.4B | — | 21.2× | 3.1× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
Peers = companies sharing CL's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $1.2B buybacks = $1.2B returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.38B 100.0% | $20.10B 100.0% | $19.46B 100.0% | $17.97B 100.0% | $17.42B 100.0% | $16.47B 100.0% | $15.69B 100.0% | $15.54B 100.0% | $15.45B 100.0% | $15.20B 100.0% |
| Cost of Revenue | $8.13B 39.9% | $7.94B 39.5% | $8.13B 41.8% | $7.72B 43.0% | $7.05B 40.4% | $6.45B 39.2% | $6.37B 40.6% | $6.31B 40.6% | $6.17B 40.0% | $6.07B 40.0% |
| Gross Profit | $12.25B 60.1% | $12.16B 60.5% | $11.33B 58.2% | $10.25B 57.0% | $10.38B 59.6% | $10.02B 60.8% | $9.32B 59.4% | $9.23B 59.4% | $9.28B 60.0% | $9.12B 60.0% |
| Research & Development | $366.0M 1.8% | $355.0M 1.8% | $343.0M 1.8% | $320.0M 1.8% | $307.0M 1.8% | $290.0M 1.8% | $281.0M 1.8% | $277.0M 1.8% | $285.0M 1.8% | $289.0M 1.9% |
| Selling, General & Admin | $7.90B 38.8% | $7.73B 38.5% | $7.15B 36.8% | $6.57B 36.5% | $6.41B 36.8% | $6.02B 36.5% | $5.58B 35.5% | $5.39B 34.7% | $5.40B 34.9% | $5.14B 33.8% |
| Operating Income | $3.31B 16.2% | $4.27B 21.2% | $3.98B 20.5% | $2.89B 16.1% | $3.33B 19.1% | $3.88B 23.6% | $3.55B 22.6% | $3.69B 23.8% | $3.71B 24.0% | $3.96B 26.0% |
| Interest Expense | $267.0M 1.3% | $292.0M 1.5% | $287.0M 1.5% | $167.0M 0.9% | $120.0M 0.7% | $184.0M 1.1% | $193.0M 1.2% | $195.0M 1.3% | $156.0M 1.0% | $155.0M 1.0% |
| Interest & Investment Income | $75.0M 0.4% | $67.0M 0.3% | $55.0M 0.3% | $14.0M 0.1% | $17.0M 0.1% | $19.0M 0.1% | $47.0M 0.3% | $50.0M 0.3% | $51.0M 0.3% | $50.0M 0.3% |
| Pretax Income | $3.06B 15.0% | $3.96B 19.7% | $3.39B 17.4% | $2.66B 14.8% | $3.09B 17.7% | $3.65B 22.1% | $3.30B 21.0% | $3.46B 22.3% | $3.49B 22.6% | $3.74B 24.6% |
| Income Tax Expense | $798.0M 3.9% | $907.0M 4.5% | $937.0M 4.8% | $693.0M 3.9% | $749.0M 4.3% | $787.0M 4.8% | $774.0M 4.9% | $906.0M 5.8% | $1.31B 8.5% | $1.15B 7.6% |
| Net Income | $2.13B 10.5% | $2.89B 14.4% | $2.30B 11.8% | $1.78B 9.9% | $2.17B 12.4% | $2.69B 16.4% | $2.37B 15.1% | $2.40B 15.4% | $2.02B 13.1% | $2.44B 16.1% |
| Per Share | ||||||||||
| EPS (Basic) | $2.64 | $3.53 | $2.78 | $2.13 | $2.56 | $3.15 | $2.76 | $2.76 | $2.30 | $2.74 |
| EPS (Diluted) | $2.63 | $3.51 | $2.77 | $2.13 | $2.55 | $3.14 | $2.75 | $2.75 | $2.28 | $2.72 |
| Weighted Avg Shares (Basic) | 808.7M | 819.1M | 827.4M | 836.4M | 845.0M | 856.8M | 859.1M | 870.6M | 881.8M | 891.8M |
| Weighted Avg Shares (Diluted) | 811.1M | 823.2M | 829.2M | 838.8M | 848.3M | 859.3M | 861.1M | 873.0M | 887.8M | 898.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-05
Nothing notable to watch.
Where each multiple sits in its own 14-yr range · 96th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 40.6 | 40.6 | 39.2 | 40.4 | 43.0 | 41.8 | 39.5 | 39.9 |
| Gross Profit | 59.4 | 59.4 | 60.8 | 59.6 | 57.0 | 58.2 | 60.5 | 60.1 |
| R&D | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 | 1.8 |
| SG&A | 34.7 | 35.5 | 36.5 | 36.8 | 36.5 | 36.8 | 38.5 | 38.8 |
| Operating Income | 23.8 | 22.6 | 23.6 | 19.1 | 16.1 | 20.5 | 21.2 | 16.2 |
| Income Tax | 5.8 | 4.9 | 4.8 | 4.3 | 3.9 | 4.8 | 4.5 | 3.9 |
| Net Income | 15.4 | 15.1 | 16.4 | 12.4 | 9.9 | 11.8 | 14.4 | 10.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on CL: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.